ARCHIVES

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

This article is from The Cancer Letter archive.

Vol. 36 No. 44 | December 3, 2010

Download PDF Visit The Full Archive

Related Articles

ONS, ASCO, AACR Growth Surge Continues; Flex Political Muscles During DC Meetings

June 8, 1990

RFPS, RFAs Available

September 23, 1994

Contracts Cutback Canceled 7 RFPs

August 8, 1980

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

In Brief: DOE honors radiation Therapy Pioneers; Center Honors Nixon, Lansing, Coffey

June 20, 1997

AACR President Coffey Urges Clinton to Support Doubling of NIH, NCI Budgets

December 19, 1997